
Nycomed requests further covenant relief
Swiss private equity-backed drug company Nycomed has asked its lenders for covenant relief as it looks at ways of managing its debts.
The company, owned by Nordic Capital, DLJ Merchant Banking, Coller International Partners and Avista, has net debt of around $3.7bn.
Nycomed reportedly asked lenders to reset its covenants in exchange for a 50 basis point fee and a 100 basis point increase in interest rates. It negotiated 25% covenant relief in March.
The firm, acquired by private equity investors in 2007, has been rumoured to be seeking an IPO as part of an exit strategy.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater